oleanolic acid has been researched along with Chondrosarcoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Elliott, S; Hays, E; Mayor, M; Sporn, M; Vincenti, M | 1 |
| Benbow, U; Brinckerhoff, CE; Mengshol, JA; Mix, KS; Sporn, MB; Vincenti, MP | 1 |
2 other study(ies) available for oleanolic acid and Chondrosarcoma
| Article | Year |
|---|---|
The triterpenoid CDDO inhibits expression of matrix metalloproteinase-1, matrix metalloproteinase-13 and Bcl-3 in primary human chondrocytes.
Topics: B-Cell Lymphoma 3 Protein; Bone Neoplasms; Cell Line, Tumor; Cells, Cultured; Chondrocytes; Chondrosarcoma; Collagenases; Dose-Response Relationship, Drug; Fibroblasts; Humans; Matrix Metalloproteinase 1; Matrix Metalloproteinase 13; Matrix Metalloproteinase Inhibitors; Oleanolic Acid; Osteoarthritis; Proto-Oncogene Proteins; Synovial Membrane; Time Factors; Transcription Factors | 2003 |
A synthetic triterpenoid selectively inhibits the induction of matrix metalloproteinases 1 and 13 by inflammatory cytokines.
Topics: Bone Neoplasms; Cell Division; Cell Movement; Chondrosarcoma; Collagen; Collagenases; Extracellular Matrix; Gene Expression Regulation, Enzymologic; Humans; Interleukin-1; Matrix Metalloproteinase 1; Matrix Metalloproteinase 13; Oleanolic Acid; Osteoarthritis; RNA, Messenger; RNA, Nuclear; Substrate Specificity; Tumor Cells, Cultured | 2001 |